Urinary 11‐Dehydro‐Thromboxane B2 as a Predictor of Acute Myocardial Infarction Outcomes: Results of Leukotrienes and Thromboxane In Myocardial Infarction (LTIMI) Study

Urinary 11‐Dehydro‐Thromboxane B2 as a Predictor of Acute Myocardial Infarction Outcomes: Results of Leukotrienes and Thromboxane In Myocardial Infarction (LTIMI) Study

BackgroundUrinary 11‐dehydro‐thromboxane (TX)B2 has been described as a potential predictive biomarker of major adverse cardiovascular events (MACEs) in high cardiac risk patients. This part of LTIMI (Leukotrienes and Thromboxane In Myocardial Infarction) study aimed to evaluate the relationship bet...

Full description

Bibliographic Details
Main Authors:	Wojciech Szczeklik, Edyta Stodółkiewicz, Marcin Rzeszutko, Marek Tomala, Anton Chrustowicz, Krzysztof Żmudka, Marek Sanak
Format:	Article
Language:	English
Published:	Wiley 2016-08-01
Series:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:	atherosclerosis complication inflammation myocardial infarction risk factor thromboxane
Online Access:	https://www.ahajournals.org/doi/10.1161/JAHA.116.003702

Similar Items

Urinary leukotriene E4 and 11-dehydro-thromboxane B2 excretion in children with bronchial asthma
by: Kaori Yoshikawa, et al.
Published: (2004-01-01)

Stability of thromboxane in blood samples
by: Helgadóttir H, et al.
Published: (2019-06-01)

Urine 11-Dehydro-Thromboxane B2 in Aspirin-Naive Males with Metabolic Syndrome
by: Wiesław Piechota, et al.
Published: (2022-06-01)

The Role of Thromboxane in the Course and Treatment of Ischemic Stroke: Review
by: Małgorzata Szczuko, et al.
Published: (2021-10-01)

Evaluation of NTP42, a novel thromboxane receptor antagonist, in a first-in-human phase I clinical trial
by: Helen M. Reid, et al.
Published: (2023-12-01)

Measurement of Thromboxane Biosynthesis in Health and Disease
by: Carlo Patrono, et al.
Published: (2019-10-01)

ADP and Thromboxane Inhibitors Both Reduce Global Contraction of Clot Length, While Thromboxane Inhibition Attenuates Internal Aggregate Contraction
by: Kevin T. Trigani, et al.
Published: (2022-04-01)

Thromboxane Mobilizes Insect Blood Cells to Infection Foci
by: Miltan Chandra Roy, et al.
Published: (2021-12-01)

A biologically active lipid, thromboxane, as a regulator of angiogenesis and lymphangiogenesis
by: Masataka Majima, et al.
Published: (2023-07-01)

NTP42, a novel antagonist of the thromboxane receptor, attenuates experimentally induced pulmonary arterial hypertension
by: Eamon P. Mulvaney, et al.
Published: (2020-04-01)

Elevated levels of leukotriene B4 and thromboxane B2 distinguish chest pain of cardiac and non cardiac origin
by: Febi John, et al.
Published: (2013-05-01)

Thromboxane-prostacyclin balance and platelet aggregability in patients with minor cardiac abnormalities
by: Aleksandr Valentinovich Yagoda, et al.
Published: (2010-09-01)

Risk Factors for Nonplatelet Thromboxane Generation After Coronary Artery Bypass Graft Surgery
by: Nikolaos Kakouros, et al.
Published: (2016-03-01)

Expression changes of prostacyclin and thromboxane in blood of rats with tail vibration
by: Ziyu CHEN, et al.
Published: (2022-11-01)

Glycyrrhizin Suppresses Lung Adenocarcinoma Cell Growth Through Inhibition of Thromboxane Synthase
by: Run-Yue Huang, et al.
Published: (2014-02-01)

The Role and Regulation of Thromboxane A<sub>2</sub> Signaling in Cancer-Trojan Horses and Misdirection
by: Anthony W. Ashton, et al.
Published: (2022-09-01)

Effect of low-dose aspirin on urinary 11-dehydro-thromboxane B2 in the ASCEND (A Study of Cardiovascular Events iN Diabetes) randomized controlled trial
by: Sarah Parish, et al.
Published: (2023-03-01)

Differential Impact of Serial Measurement of Nonplatelet Thromboxane Generation on Long‐Term Outcome After Cardiac Surgery
by: Nikolaos Kakouros, et al.
Published: (2017-11-01)

Activation of thromboxane A2 receptors mediates endothelial dysfunction in diabetic mice
by: Xiaona Xie, et al.
Published: (2017-05-01)

Investigation of a Thromboxane A2 Receptor–Based Vaccine for Managing Thrombogenesis
by: Fatima Z. Alshbool, et al.
Published: (2018-07-01)

Rivaroxaban reduces thromboxane induced platelet aggregation - the forgotten compass arm?
by: Lisa Dannenberg, et al.
Published: (2021-11-01)

High Levels of Thromboxane (TX) Are Associated with the Sex-Dependent Non-Dipping Phenomenon in Ischemic Stroke Patients
by: Arleta Drozd, et al.
Published: (2022-05-01)

Positive effect of low-activity thromboxane A synthase 1 gene on prognosis in coronary heart disease
by: F Yu Kopylov, et al.
Published: (2015-03-01)

Effects of KP-496, a Novel Dual Antagonist for Leukotriene D4 and Thromboxane A2 Receptors, on Contractions Induced by Various Agonists in the Guinea Pig Trachea
by: Masakazu Ishimura, et al.
Published: (2006-01-01)

Additive damage in the thromboxane related vasoconstriction and bradykinin relaxation of intramural coronary resistance arterioles in a rodent model of andropausal hypertension
by: Attila Jósvai, et al.
Published: (2022-11-01)

Anti-thromboxane B2 antibodies protect against acetaminophen-induced liver injury in mice
by: Ivan Ćavar, et al.
Published: (2011-12-01)

Semi-Mechanistic Modeling of HY-021068 Based on Irreversible Inhibition of Thromboxane Synthetase
by: Ping Li, et al.
Published: (2020-11-01)

Variations in white blood count, thromboxane B2 levels and hematocrit in chronic venous hypertension
by: Paulo Celso Motta Guimarães, et al.

Thromboxane A2 receptor stimulation enhances microglial interleukin-1β and NO biosynthesis mediated by the activation of ERK pathway
by: Wanlin eYang, et al.
Published: (2016-01-01)

Calcium-Dependent Src Phosphorylation and Reactive Oxygen Species Generation Are Implicated in the Activation of Human Platelet Induced by Thromboxane A2 Analogs
by: Pietro Minuz, et al.
Published: (2018-09-01)

Fetal Sex and Fetal Environment Interact to Alter Diameter, Myogenic Tone, and Contractile Response to Thromboxane Analog in Rat Umbilical Cord Vessels
by: Benoit Sicotte, et al.
Published: (2021-09-01)

Androgen Deprivation Therapy in Patients With Prostate Cancer Increases Serum Levels of Thromboxane A2: Cardiovascular Implications
by: Mario Álvarez-Maestro, et al.
Published: (2021-04-01)

Associations of P-selectin and Thromboxane B2 Expression Levels with Efficacy and Prognosis in Patients with Ischemic Stroke Affecting Different Parts of the Brain
by: Cancan MENG, Yan CHENG, Liyan JIAO, Zhiwei ZHANG, Weigang LIU, Zhitang YANG
Published: (2022-05-01)

Daidzein Inhibits Human Platelet Activation by Downregulating Thromboxane A<sub>2</sub> Production and Granule Release, Regardless of COX-1 Activity
by: Hyun-Jin Hong, et al.
Published: (2023-07-01)

The thromboxane receptor antagonist NTP42 promotes beneficial adaptation and preserves cardiac function in experimental models of right heart overload
by: Eamon P. Mulvaney, et al.
Published: (2022-12-01)

Effects of AT1 Receptor Blockade on Plasma Thromboxane A2 (TXA2) Level and Skin Microcirculation in Young Healthy Women on Low Salt Diet
by: Ana Cavka, et al.
Published: (2013-10-01)

Platelet dysfunction caused by a novel thromboxane A2 receptor mutation and congenital thrombocytopenia in a case of mild bleeding
by: Peter Bugert, et al.
Published: (2020-02-01)

Aspirin resistance status as determined by urinary thromboxane B2 (TXB2) level in patients with ischemic heart disease and its relationship with Severity of coronary artery disease
by: Naghmeh Ziaie, et al.
Published: (2011-01-01)

Adherence to the Mediterranean Diet Association with Serum Levels of Nitric Oxide, Prostacyclin, and Thromboxane B<sub>2</sub> among Prinzmetal Angina Patients and Healthy Persons
by: Mahsa Mohajeri, et al.
Published: (2023-02-01)

Increased Thromboxane A<sub>2</sub> Levels in Pulmonary Artery Smooth Muscle Cells Isolated from Patients with Chronic Obstructive Pulmonary Disease
by: Abdullah A. Alqarni
Published: (2023-01-01)